… the playing field for cancer immunotherapy. Summarized in … related to tumor immunology
and cancer immunotherapy, … therapy, anti-tumor antibodies, cancer vaccines, and immune …

… -tumor immune responses. Here, we summarize the 2012 SITC Primer, reviewing past, present,
and emerging immunotherapeutic approaches for the treatment of cancer—… of the tumor …

… both viral and tumor models to confer superior protective and therapeutic immunity compared
to T EM/EFF , might be a critical key for improving cancer immunotherapies and vaccines. …

… et al., 2012) in solid tumors and the engineered T cell therapy in acute lymphoblastic leukemia
(ALL) opened the new era of cancer immunotherapy as a monotherapy or in combination …

… We are currently living in an era of cancer immunotherapy. Several ICIs and CAR-T cell
therapies have already been approved by regulatory agencies for the treatment of …

… Within the past two decades, the field of cancer immunotherapy has grown, not only as
an academic discipline, but also as a viable treatment option for many cancer sufferers. …

… Here, we discuss the current immunotherapeutic strategies against cancer highlighting the
… We also discuss the value of tumor neoantigens in the patients’ response to immunotherapy…

… tumors established in immunocompetent versus immunodeficient animals were critical in
the early days of modern tumor immunology, as … the immunological versus non-immunological …

… of tumor immunology.[ 1 ] Moreover, a variety of immunotherapeutic strategies have shown
… immune manipulation can mediate the regression of established cancer in humans.[ 2 3 ] …

Historically, non-small-cell lung cancer (NSCLC) has been regarded as a nonimmunogenic
tumor; however, recent studies have shown that NSCLCs are among the most responsive …